Pune News | Press Trust of India | Wednesday August 26, 2020
The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the Pune-based Serum Institute of India (SII), began at a medical college and hospital in the city today.
www.ndtv.com